WCN26-6583 ORAL LACTOFERRIN IN ANEMIA OF CHRONIC KIDNEY DISEASE: A SYSTEMATIC REVIEW AND META-ANALYSIS

Read full text Summarise with VIRAT
Authors: Abhijith Magal, Felemez Arslan, Rafaela Pereira Silva, Elena Bayer, Vitor Paiva de Almeida
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Anemia is a prevalent and multifactorial complication of chronic kidney disease (CKD), often driven by inflammation, impaired iron metabolism, and reduced erythropoietin production. Lactoferrin, an iron-binding glycoprotein with immunomodulatory and antimicrobial properties, has demonstrated efficacy in improving iron indices in general iron deficiency anemia. However, its role in CKD-associated anemia remains inadequately characterized.

Fields of Study & Subjects

Erythropoietin and Anemia Treatment Iron Metabolism and Disorders Dialysis and Renal Disease Management

Publication details

Journal / source
Kidney International Reports
Volume
11
Issue
4
Pages
106030–106030
Publication date
25 March 2026
Language
EN